MedPath

Comparison Between Three Freezing Protocols to Preserve Human Embryos

Not Applicable
Completed
Conditions
Human Embryo Cryopreservation
Interventions
Other: Slow freezing
Other: VIT-Irvine
Other: Vit-Vitrolife
Registration Number
NCT00910390
Lead Sponsor
Erasme University Hospital
Brief Summary

This randomized study compares three different freezing methods to store human in vitro fertilization (IVF) embryos: vitrification with two commercial kits or slow freezing. After information, all patients undergoing IVF treatment can be included in the study. If qualified, embryos at different developmental stages will be allocated between the three methods. At the end of the first year survival and developmental rates, and implantation and pregnancy rates will be analyzed in order to determine the best method.

Detailed Description

Despite all the advances achieved in vitro fertilized treatments, it is known that the chances of implantation for fertilised in vitro embryo remain limited, at around 20%. Cryopreservation of supernumerary embryos produced during IVF cycles provides an opportunity for patients to increase the number of transfers per oocyte harvest cycle, increasing then their chances of conception.

The freezing technique may involve different media and methods, which lead to different survival and developmental rates after thawing.

Vitrification is a new freezing method, which consists in exposing cells to high concentrations of cryoprotectants and then cooling them ultra-rapidly; this induces an increase in viscosity which favours the formation of a vitreous state without any ice crystals formation. This method contrasts with the slow freezing method (currently employed), which is based on exposure to very low concentrations of cryoprotectants combined with long cooling times and associated with a higher risk of ice crystal formation.

Both methods can reduce cell survival and embryo ability to develop, either by the high concentrations of cryoprotectants in case of vitrification, or by ice crystals formation in case of slow freezing. The advantages of vitrification in embryology may be considerable because embryos seem more sensitive to ice crystal formation than to cyroportectant concentration; consequently, the elimination of office crystal injury may increase their survival chances. Additionally in the case of vitrification, the time required for equilibration and cooling is considerably reduced as well as the need for expensive equipment such as programmable machine is eliminated.

At present, vitrification and slow freezing are used for the cryopreservation of oocytes and embryos at all stages of development. Encouraging results have been obtained with vitrification, but no study has randomly compared in one study, the two protocols and cryoprotectors. The purpose of this clinic randomised study is to compare three treatments: traditional slow freezing method currently employed (control group) and two different commercial vitrification methods (experimental groups) to assess the efficacy that this technique may involve.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
584
Inclusion Criteria
  • Infertility requiring IVF
Exclusion Criteria
  • Women's age > 43 years
  • Patients positive for hepatitis B or C
  • Patients positive for HIV

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Slow FreezingSlow freezingStandard freezing protocol (slow freezing) of preimplantation embryos
VIT-IrvineVIT-IrvineVitrification with Irvine solution (rapid freezing) of preimplantation embryos
VIT-VitrolifeVit-VitrolifeVitrification (rapid freezing) with Vitrolife solution
Primary Outcome Measures
NameTimeMethod
Survival embryo rateone year
Secondary Outcome Measures
NameTimeMethod
Delivery rateone year

Trial Locations

Locations (1)

IVF laboratory, Hospital Erasme, Route de Lennik 808

🇧🇪

Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath